Q2 2026 Call Likely Tests ERP Recovery Thesis; Wait for 10-K Remediation Proof

What happened

Vital Farms' Q2 2026 earnings call comes at a pivotal moment, with the market seeking clarity on whether the ERP-driven order disruption that led to the December 2025 guidance cut has fully normalized. The DeepValue master report had placed a WAIT rating, emphasizing that the FY2025 10-K must confirm remediation of the material weakness in revenue-process controls and that early 2026 guidance must hold to restore credibility. While the transcript details are not available, the call likely addressed second-quarter revenue trends, margin performance, and the status of the ERP hypercare exit that management had promised by December 2025. Importantly, the 180-day checkpoint from the report expires in days, making any deviation from the $930–$950 million revenue outlook a potential thesis breaker. Investors should remain cautious until they can assess whether the controls weakness was actually fixed and whether consumer demand for premium eggs held up amid volatile egg prices.

Implication

If management confirmed that ERP systems are now stable and reiterated the full-year revenue target, it reduces the immediate guide-down risk but does not dissolve the governance overhang from the unremediated material weakness. The brand’s ability to convert strong consumer demand into reliable order flows will be tested by the back half of 2026 as capacity investments ramp. Until the 10-K shows a clean controls opinion, the cost of capital and repeat uncertainty risk justify limiting exposure. Conversely, any hint of renewed order friction or a soft demand commentary would quickly reprice the stock toward the bear-case $21 implied value. With the stock likely trading above the $24 attractive entry from the earlier report, upside is now contingent on flawless execution into 2027.

Thesis delta

The original thesis called for a WAIT until FY2025 10-K proves remediation and early 2026 guidance is reaffirmed. The Q2 2026 call marks the halfway point of that proof period; preliminary signals of stabilization would edge the thesis toward a more constructive posture, but conclusive evidence is still absent. A full shift to a BUY case requires visible normalization in both financial controls and ordering cadence, which this call alone cannot fully supply.